{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:33:48Z","timestamp":1783467228634,"version":"3.55.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["F32DK132836"],"award-info":[{"award-number":["F32DK132836"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK129259"],"award-info":[{"award-number":["R01DK129259"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001296","name":"PKD Foundation","doi-asserted-by":"publisher","award":["241G20a"],"award-info":[{"award-number":["241G20a"]}],"id":[{"id":"10.13039\/100001296","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Kidney Disease and Health"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1053\/j.akdh.2022.12.008","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T20:53:58Z","timestamp":1682110438000},"page":"220-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Nonpharmacological Management of Autosomal Dominant Polycystic Kidney Disease"],"prefix":"10.1053","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5701-1240","authenticated-orcid":false,"given":"Cortney N.","family":"Steele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9364-3256","authenticated-orcid":false,"given":"Kristen L.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1053\/j.akdh.2022.12.008_bib1","first-page":"e13","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.008_bib2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.kint.2020.10.026","article-title":"Executive summary of the KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease","volume":"99","author":"Cheung","year":"2021","journal-title":"Kidney Int"},{"issue":"24","key":"10.1053\/j.akdh.2022.12.008_bib3","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","article-title":"Blood pressure in early autosomal dominant polycystic kidney disease","volume":"371","author":"Schrier","year":"2014","journal-title":"New Engl J Med"},{"issue":"24","key":"10.1053\/j.akdh.2022.12.008_bib4","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1056\/NEJMoa1402686","article-title":"Angiotensin blockade in late autosomal dominant polycystic kidney disease","volume":"371","author":"Torres","year":"2014","journal-title":"New Engl J Med"},{"issue":"22","key":"10.1053\/j.akdh.2022.12.008_bib5","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1053\/j.akdh.2022.12.008_bib6","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1681\/ASN.2017020148","article-title":"Effects of intensive BP control in CKD","volume":"28","author":"Cheung","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.akdh.2022.12.008_bib7","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2215\/CJN.05850518","article-title":"Vascular dysfunction, oxidative stress, and inflammation in autosomal dominant polycystic kidney disease","volume":"13","author":"Nowak","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.008_bib8","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1053\/j.ajkd.2005.02.026","article-title":"Arterial stiffness in renal patients: an update","volume":"45","author":"Covic","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1053\/j.akdh.2022.12.008_bib9","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1681\/ASN.V5122048","article-title":"Causes of death in autosomal dominant polycystic kidney disease","volume":"5","author":"Fick","year":"1995","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.008_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1161\/HYPERTENSIONAHA.117.10439","article-title":"Strategies for achieving healthy vascular aging","volume":"71","author":"Nowak","year":"2018","journal-title":"Hypertension"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.008_bib11","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12882-017-0641-3","article-title":"Understanding barriers to medication, dietary, and lifestyle treatments prescribed in polycystic kidney disease","volume":"18","author":"Tran","year":"2017","journal-title":"BMC Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.008_bib12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3945\/an.115.009753","article-title":"Dietary patterns and blood pressure in adults: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Ndanuko","year":"2016","journal-title":"Adv Nutr"},{"issue":"11","key":"10.1053\/j.akdh.2022.12.008_bib13","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.2215\/CJN.03960318","article-title":"Recent advances in the management of autosomal dominant polycystic kidney disease","volume":"13","author":"Chebib","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2022.12.008_bib14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2215\/CJN.13291019","article-title":"Metabolic reprogramming in autosomal dominant polycystic kidney disease: evidence and therapeutic potential","volume":"15","author":"Nowak","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.akdh.2022.12.008_bib15","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41581-019-0183-y","article-title":"The pathobiology of polycystic kidney disease from a metabolic viewpoint","volume":"15","author":"Menezes","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"Suppl 1","key":"10.1053\/j.akdh.2022.12.008_bib65","doi-asserted-by":"crossref","first-page":"i27","DOI":"10.1093\/ckj\/sfy089","article-title":"S.L. Kruger and B.C. Bourgeois, Emerging targeted strategies for the treatment of autosomal dominant polycystic kidney disease","volume":"11","author":"Weimbs","year":"2018","journal-title":"Clin Kidney J"},{"issue":"11","key":"10.1053\/j.akdh.2022.12.008_bib16","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41581-018-0051-1","article-title":"Metabolism and mitochondria in polycystic kidney disease research and therapy","volume":"14","author":"Padovano","year":"2018","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2022.12.008_bib17","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1681\/ASN.2015020132","article-title":"Food restriction ameliorates the development of polycystic kidney disease","volume":"27","author":"Warner","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.akdh.2022.12.008_bib18","doi-asserted-by":"crossref","first-page":"F726","DOI":"10.1152\/ajprenal.00551.2015","article-title":"A mild reduction of food intake slows disease progression in an orthologous mouse model of polycystic kidney disease","volume":"310","author":"Kipp","year":"2016","journal-title":"Am J Renal Physiol"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.008_bib19","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.cmet.2019.09.012","article-title":"Ketosis ameliorates renal cyst growth in polycystic kidney disease","volume":"30","author":"Torres","year":"2019","journal-title":"Cell Metab"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.008_bib20","doi-asserted-by":"crossref","first-page":"103697","DOI":"10.1016\/j.isci.2021.103697","article-title":"Weight loss and cystic disease progression in autosomal dominant polycystic kidney disease","volume":"25","author":"Hopp","year":"2022","journal-title":"iScience"},{"key":"10.1053\/j.akdh.2022.12.008_bib66","first-page":"gfac311","article-title":"A pilot trial on short-term ketogenic interventions in autosomal dominant polycystic kidney disease","author":"Oehm","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.akdh.2022.12.008_bib21","doi-asserted-by":"crossref","first-page":"100206","DOI":"10.1016\/j.phanu.2020.100206","article-title":"GREASE II. A phase II randomized, 12-month, parallel-group, superiority study to evaluate the efficacy of a modified atkins diet in autosomal dominant polycystic kidney disease patients","volume":"13","author":"Testa","year":"2020","journal-title":"PharmaNutrition"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.008_bib22","doi-asserted-by":"crossref","first-page":"550","DOI":"10.2215\/CJN.04071206","article-title":"Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease","volume":"2","author":"Wahba","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.008_bib23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1681\/ASN.2017070819","article-title":"Overweight and obesity are predictors of progression in early autosomal dominant polycystic kidney disease","volume":"29","author":"Nowak","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.008_bib24","doi-asserted-by":"crossref","first-page":"908","DOI":"10.2215\/CJN.16871020","article-title":"Overweight and obesity and progression of ADPKD","volume":"16","author":"Nowak","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2022.12.008_bib25","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.xkme.2021.03.004","article-title":"Pain and obesity in autosomal dominant polycystic kidney disease: a post hoc analysis of the Halt Progression of Polycystic Kidney Disease (HALT-PKD) studies","volume":"3","author":"Nowak","year":"2021","journal-title":"Kidney Med"},{"issue":"25 Suppl 2","key":"10.1053\/j.akdh.2022.12.008_bib26","first-page":"S102","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American heart association task force on practice guidelines and the obesity Society","volume":"129","author":"Jensen","year":"2014","journal-title":"Circulation"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.008_bib27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11906-008-0008-z","article-title":"Intra-abdominal adiposity, inflammation, and cardiovascular risk: new insight into global cardiometabolic risk","volume":"10","author":"Calabro","year":"2008","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.008_bib28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1681\/ASN.2013040398","article-title":"Strategies targeting cAMP signaling in the treatment of polycystic kidney disease","volume":"25","author":"Torres","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.008_bib29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.ki.5002229","article-title":"Hyperproliferation of PKD1 cystic cells is induced by insulin-like growth factor-1 activation of the Ras\/Raf signalling system","volume":"72","author":"Parker","year":"2007","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.008_bib30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/kidneydial2010013","article-title":"Obesity, Weight loss, lifestyle interventions, and autosomal dominant polycystic kidney disease","volume":"2","author":"Steele","year":"2022","journal-title":"Kidney Dial"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.008_bib31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/ndt\/gfu044","article-title":"Metabolic abnormalities in autosomal dominant polycystic kidney disease","volume":"30","author":"Mao","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1053\/j.akdh.2022.12.008_bib32","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1093\/ndt\/gfr744","article-title":"The impact of type II diabetes mellitus in patients with autosomal dominant polycystic kidney disease","volume":"27","author":"Reed","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.008_bib33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00109-015-1337-4","article-title":"Glucose promotes secretion-dependent renal cyst growth","volume":"94","author":"Kraus","year":"2016","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.008_bib34","doi-asserted-by":"crossref","first-page":"F79","DOI":"10.1152\/ajprenal.00652.2014","article-title":"Hyperglycemia in the absence of cilia accelerates cystogenesis and induces renal damage","volume":"309","author":"Sas","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"10.1053\/j.akdh.2022.12.008_bib35","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/ckj\/sft031","article-title":"Hypertension in autosomal-dominant polycystic kidney disease (ADPKD)","volume":"6","author":"Sans-Atxer","year":"2013","journal-title":"Clin Kidney J"},{"issue":"Suppl 1","key":"10.1053\/j.akdh.2022.12.008_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000463063","article-title":"Polycystic kidney disease and the vasopressin pathway","volume":"70","author":"van Gastel","year":"2017","journal-title":"Ann Nutr Metab"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.008_bib37","doi-asserted-by":"crossref","first-page":"F261","DOI":"10.1152\/ajprenal.00345.2014","article-title":"Effects of hydration in rats and mice with polycystic kidney disease","volume":"308","author":"Hopp","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.008_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-018794","article-title":"Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)","volume":"8","author":"Wong","year":"2018","journal-title":"BMJ Open"},{"issue":"4","key":"10.1053\/j.akdh.2022.12.008_bib39","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/qjmed\/hcz278","article-title":"High water vs. ad libitum water intake for autosomal dominant polycystic kidney disease: a randomized controlled feasibility trial","volume":"113","author":"El-Damanawi","year":"2020","journal-title":"QJM"},{"issue":"9","key":"10.1053\/j.akdh.2022.12.008_bib40","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/ndt\/gfu093","article-title":"Does increased water intake prevent disease progression in autosomal dominant polycystic kidney disease?","volume":"29","author":"Higashihara","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1053\/j.akdh.2022.12.008_bib41","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1097\/01.ASN.0000025282.48298.7B","article-title":"The effect of caffeine on renal epithelial cells from patients with autosomal dominant polycystic kidney disease","volume":"13","author":"Belibi","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2022.12.008_bib42","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.33594\/000000072","article-title":"Caffeine accelerates cystic kidney disease in a Pkd1-deficient mouse model","volume":"52","author":"Meca","year":"2019","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.008_bib43","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s12882-018-1182-0","article-title":"Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort","volume":"19","author":"McKenzie","year":"2018","journal-title":"BMC Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.008_bib44","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s40620-017-0396-8","article-title":"Long-term effect of coffee consumption on autosomal dominant polycystic kidneys disease progression: results from the Suisse ADPKD, a prospective longitudinal cohort study","volume":"31","author":"Girardat-Rotar","year":"2018","journal-title":"J Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2022.12.008_bib45","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1053\/ajkd.2001.28614","article-title":"Chronic caffeine consumption exacerbates hypertension in rats with polycystic kidney disease","volume":"38","author":"Tanner","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.008_bib46","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3390\/nu10060732","article-title":"Dietary salt restriction in chronic kidney disease: a meta-analysis of randomized clinical trials","volume":"10","author":"Garofalo","year":"2018","journal-title":"Nutrients"},{"key":"10.1053\/j.akdh.2022.12.008_bib47","series-title":"Sodium Intake in Populations: Assessment of Evidence","year":"2013"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.008_bib48","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2215\/CJN.03250410","article-title":"Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease","volume":"6","author":"Torres","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.008_bib49","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.kint.2016.10.018","article-title":"Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease","volume":"91","author":"Torres","year":"2017","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.akdh.2022.12.008_bib50","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.kint.2020.04.053","article-title":"Salt, but not protein intake, is associated with accelerated disease progression in autosomal dominant polycystic kidney disease","volume":"98","author":"Kramers","year":"2020","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.akdh.2022.12.008_bib51","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1681\/ASN.2015010022","article-title":"Urinary sodium and potassium excretion and CKD progression","volume":"27","author":"He","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.008_bib52","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1681\/ASN.V561355","article-title":"Early dietary protein restriction slows disease progression and lengthens survival in mice with polycystic kidney disease","volume":"5","author":"Tomobe","year":"1994","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.akdh.2022.12.008_bib53","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1681\/ASN.V5122037","article-title":"Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group","volume":"5","author":"Klahr","year":"1995","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.008_bib54","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1523-1755.2000.00835.x","article-title":"Modification of polycystic kidney disease and fatty acid status by soy protein diet","volume":"57","author":"Ogborn","year":"2000","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.008_bib55","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/advances\/nmab131","article-title":"Dietary interventions in autosomal dominant polycystic kidney disease","volume":"13","author":"Pickel","year":"2021","journal-title":"Adv Nutr"},{"issue":"5","key":"10.1053\/j.akdh.2022.12.008_bib56","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1053\/j.ajkd.2015.07.037","article-title":"Autosomal dominant polycystic kidney disease: Core Curriculum 2016","volume":"67","author":"Chebib","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1053\/j.akdh.2022.12.008_bib57","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ekir.2019.06.002","article-title":"Strategies for phosphate control in patients with CKD","volume":"4","author":"Barreto","year":"2019","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.008_bib58","doi-asserted-by":"crossref","first-page":"F35","DOI":"10.1152\/ajprenal.00282.2019","article-title":"Dietary phosphate restriction attenuates polycystic kidney disease in mice","volume":"318","author":"Omede","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"issue":"10","key":"10.1053\/j.akdh.2022.12.008_bib59","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1172\/JCI128503","article-title":"Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease","volume":"129","author":"Torres","year":"2019","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1053\/j.akdh.2022.12.008_bib60","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1681\/ASN.V971242","article-title":"Potassium citrate\/citric acid intake improves renal function in rats with polycystic kidney disease","volume":"9","author":"Tanner","year":"1998","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2022.12.008_bib61","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3390\/nu10040512","article-title":"Dietary treatment of metabolic acidosis in chronic kidney disease","volume":"10","author":"Siener","year":"2018","journal-title":"Nutrients"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.008_bib62","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.clnu.2016.01.003","article-title":"Diet and polycystic kidney disease: a pilot intervention study","volume":"36","author":"Taylor","year":"2017","journal-title":"Clin Nutr"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.008_bib63","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000045588","article-title":"Effects of potassium citrate\/citric acid intake in a mouse model of polycystic kidney disease","volume":"84","author":"Tanner","year":"2000","journal-title":"Nephron"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.008_bib64","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2215\/CJN.07820618","article-title":"Urinary potassium excretion and progression of CKD","volume":"14","author":"Kim","year":"2019","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Advances in Kidney Disease and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813922000337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813922000337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:38:52Z","timestamp":1757432332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949813922000337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2949813922000337"],"URL":"https:\/\/doi.org\/10.1053\/j.akdh.2022.12.008","relation":{},"ISSN":["2949-8139"],"issn-type":[{"value":"2949-8139","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonpharmacological Management of Autosomal Dominant Polycystic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Advances in Kidney Disease and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.akdh.2022.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}